DBV Technologies is participating in investor conferences in September

DBV Technologies, a late-stage biopharmaceutical company, announced its participation in several investor conferences in September 2026. On September 9, it will speak at the Cantor Global Healthcare Conference in New York in an informal discussion format. The following day, it will participate in Citi's Biopharma Back to School Conference for one-on-one meetings. Finally, on September 15, another informal discussion will be held at the HC Wainwright 28th Annual Global Investment Conference, also in New York.

The informal discussions will be broadcast live on the "Events" section of the DBV Technologies website and will remain accessible for 90 days.